Skip to main content
Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
101.36
-0.63 (-0.62%)
At close: Dec 5, 2025, 4:00 PM EST
101.31
-0.05 (-0.05%)
After-hours: Dec 5, 2025, 7:46 PM EST

Medtronic Revenue by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Cardiovascular
13.09B 12.76B 12.48B 12.28B 12.17B 11.99B 11.83B 12.00B
Cardiovascular Growth
7.61% 6.43% 5.49% 2.27% 2.71% 2.50% 2.35% 7.00%
Neuroscience
10.06B 9.95B 9.85B 9.77B 9.67B 9.51B 9.41B 9.27B
Neuroscience Growth
4.01% 4.63% 4.67% 5.38% 5.49% 4.88% 5.00% 4.79%
Medical Surgery
8.54B 8.50B 8.41B 8.39B 8.47B 8.48B 8.53B 8.45B
Medical Surgery Growth
0.80% 0.13% -1.40% -0.70% 0.33% 1.36% 2.34% 0.17%
Diabetes
2.90B 2.83B 2.76B 2.69B 2.63B 2.56B 2.49B 2.42B
Diabetes Growth
10.14% 10.64% 10.73% 10.90% 11.90% 11.22% 9.99% 7.02%

Revenue by Geography
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
United States
17.52B 17.31B 17.17B 16.97B 16.85B 16.72B 16.56B 16.70B
United States Growth
4.01% 3.54% 3.67% 1.62% 1.27% 1.14% 1.15% 4.38%
Rest of World
17.23B 16.89B 16.37B 16.23B 16.15B 15.86B 15.80B 15.62B
Rest of World Growth
6.74% 6.51% 3.58% 3.90% 5.40% 5.52% 6.38% 5.72%

Operating Expense Breakdown
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Selling, General, and Administrative
11.21B 11.00B 10.85B 10.89B 10.85B 10.78B 10.74B 10.59B
Selling, General, and Administrative Growth
3.31% 2.06% 1.05% 2.89% 3.04% 3.04% 3.09% 2.12%
Research and Development
2.84B 2.78B 2.73B 2.72B 2.74B 2.74B 2.74B 2.70B
Research and Development Growth
3.50% 1.38% -0.15% 0.81% 1.82% 2.69% 1.48% -0.26%
Amortization
1.90B 1.85B 1.81B 1.66B 1.67B 1.68B 1.69B 1.70B
Amortization Growth
14.23% 10.44% 6.80% -2.00% -2.52% -1.58% -0.35% -0.82%
Litigation
- 344.00M 361.00M 212.00M - 230.00M 119.00M - 110.00M 79.00M 65.00M - - - -
Litigation Growth
- 189.08% 228.18% 168.35% - 253.85% - - - - - - - - -
Restructuring
245.00M 265.00M 267.00M 232.00M 209.00M 219.00M 226.00M 408.00M
Restructuring Growth
17.22% 21.00% 18.14% -43.14% -50.94% -47.36% -39.89% 270.91%
Other Expenses
102.00M 46.00M -23.00M 439.00M 461.00M 464.00M 464.00M 43.00M
Other Expenses Growth
-77.87% -90.09% - 920.93% - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.